A
Angel Li
Researcher at Mount Sinai Hospital
Publications - 10
Citations - 793
Angel Li is an academic researcher from Mount Sinai Hospital. The author has contributed to research in topics: Medicine & Disease. The author has an hindex of 3, co-authored 3 publications receiving 374 citations. Previous affiliations of Angel Li include Lunenfeld-Tanenbaum Research Institute.
Papers
More filters
Journal ArticleDOI
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
Baweleta Isho,Kento T. Abe,Kento T. Abe,Michelle Zuo,Alainna J Jamal,Alainna J Jamal,Bhavisha Rathod,Jenny Wang,Zhijie Li,Gary Chao,Olga L. Rojas,Yeo Myong Bang,Annie Pu,Natasha Christie-Holmes,Christian Gervais,Derek F. Ceccarelli,Payman Samavarchi-Tehrani,Furkan Guvenc,Patrick Budylowski,Angel Li,Aimee Paterson,Feng Yun Yue,Lina María Marín,Lauren Caldwell,Jeffrey L. Wrana,Jeffrey L. Wrana,Karen Colwill,Frank Sicheri,Frank Sicheri,Samira Mubareka,Scott D. Gray-Owen,Steven J. Drews,Walter L. Siqueira,Miriam Barrios-Rodiles,Mario A. Ostrowski,Mario A. Ostrowski,James M. Rini,Yves Durocher,Allison McGeer,Allison McGeer,Allison McGeer,Jennifer L. Gommerman,Anne-Claude Gingras,Anne-Claude Gingras +43 more
TL;DR: It is confirmed that serum and saliva IgG antibodies to SARS-CoV-2 are maintained in the majority of COVID-19 patients for at least 3 months PSO, and IgG responses in saliva may serve as a surrogate measure of systemic immunity to Sars-Cov-2 based on their correlation with serum IgG responds.
Journal ArticleDOI
Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection
Salma Sheikh-Mohamed,Baweleta Isho,Gary Chao,Michelle Zuo,Carmit Cohen,Yaniv Lustig,George Nahass,Rachel E. Salomon-Shulman,Grace Blacker,Mahya Fazel-Zarandi,Bhavisha Rathod,Karen Colwill,Alainna J Jamal,Zhijie Li,Keelia Quinn de Launay,Alyson Takaoka,Julie Garnham-Takaoka,Anjali Patel,Christine Fahim,Aimee Paterson,Angel Li,Nazrana Haq,Shiva Barati,L. H Gilbert,Karen Green,Mohammad Mozafarihashjin,Philip G. Samaan,Patrick Budylowski,Walter L. Siqueira,Samira Mubareka,Mario A. Ostrowski,James M. Rini,Olga L. Rojas,Irving L. Weissman,Michal Caspi Tal,Allison McGeer,Gili Regev-Yochay,Sharon E. Straus,Anne-Claude Gingras,Jennifer L. Gommerman +39 more
TL;DR: In this article , the authors collected serum and saliva samples from participants receiving two doses of mRNA COVID-19 vaccines and measured the level of anti-SARS-CoV-2 Ab.
Journal ArticleDOI
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
Karen Colwill,Yannick Galipeau,Matthew Stuible,Christian Gervais,Corey R. Arnold,Bhavisha Rathod,Kento T. Abe,Jenny Wang,Adrian Pasculescu,Maria N. Maltseva,Lynda Rocheleau,Martin Pelchat,Mahya Fazel-Zarandi,Mariam Iskilova,Miriam Barrios-Rodiles,Linda Bennett,Kevin Yau,François Cholette,C. Mesa,Angel Li,Aimee Paterson,Michelle Hladunewich,Pamela J. Goodwin,Jeffrey L. Wrana,Steven J. Drews,Samira Mubareka,Allison McGeer,John E. Kim,Marc-André Langlois,Anne-Claude Gingras,Yves Durocher +30 more
TL;DR: A scalable solution to detect and quantify SARS‐CoV‐2 antibodies, discriminate between natural infection‐ and vaccination‐induced responses, and assess antibody‐mediated inhibition of the spike‐angiotensin converting enzyme 2 (ACE2) interaction is described.
Posted ContentDOI
Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers
Kento T. Abe,Kento T. Abe,Queenie Hu,Mohammad Mozafarihashjin,Mohammad Mozafarihashjin,Reuben Samson,Reuben Samson,Kathy Manguiat,Alyssia Robinson,Bhavisha Rathod,W. Rod Hardy,Jenny Wang,Mariam Iskilova,Adrian Pasculescu,Mahya Fazel-Zarandi,Angel Li,Aimee Paterson,Gary Chao,Karen Green,Lois Gilbert,Lois Gilbert,Shiva Barati,Shiva Barati,Nazrana Haq,Nazrana Haq,Alyson Takaoka,Julia Garnham Takaoka,Keelia Quinn De Launay,Keelia Quinn De Launay,Christine Fahim,Salma Sheikh-Mohamed,Yuko Arita,Yves Durocher,Eric G. Marcusson,Jennifer L. Gommerman,Mario A. Ostrowski,Mario A. Ostrowski,Mario A. Ostrowski,Karen Colwill,Sharon E. Straus,Sharon E. Straus,Heidi Wood,Allison McGeer,Allison McGeer,Allison McGeer,Anne-Claude Gingras,Anne-Claude Gingras +46 more
TL;DR: For example, residents who received mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) vaccines reported 4.8-6.3-fold reduction in neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS2) in LTCH residents.
Posted ContentDOI
A mucosal antibody response is induced by intra-muscular SARS-CoV-2 mRNA vaccination
Salma Sheikh Mohamed,Gary Y.C. Chao,Baweleta Isho,Michelle Zuo,George R. Nahass,Rachel E. Salomon-Shulman,Grace Blacker,Mahya Fazel-Zarandi,Bhavisha Rathod,Karen Colwell,Alainna Jamal,Zhijie Li,Keelia Quinn de Launay,Alyson Takaoka,Christine Fahim,Aimee Paterson,Angel Li,Julia Garnham-Takaoka,Nazrana Haq,Shiva Barati,Lois Gilbert,Karen Green,Mohammad Mozafarihashjin,Philip Samaan,Walter L. Siqueira,Samira Mubareka,Samira Mubareka,Mario A. Ostrowski,James M. Rini,Olga L. Rojas,Allison McGeer,Irving L. Weissman,Michal Caspi-Tal,Sharon E Strauss,Anne-Claude Gingras,Anne-Claude Gingras,Jen Gommerman,Patrick Budylowski +37 more
TL;DR: In this paper, salivary antibodies against SARS-CoV-2 Spike protein and its receptor binding domain (RBD) following 2 i.m. injections of either BNT162b2 or mRNA-1273 vaccines were analyzed.